Correction to “Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials”,American Journal of Hematology

当前位置： X-MOL 学术 › Am. J. Hematol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Correction to “Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials”
American Journal of Hematology ( IF 10.1 ) Pub Date : 2024-06-11 , DOI: 10.1002/ajh.27380

Sidiqi MH, Al Saleh AS, Kumar SK, Leung N, Jevremovic D, Muchtar E, Gonsalves WI, Kourelis TV, Warsame R, Buadi FK, Lacy MQ, Kyle RA, Go R, Hobbs M, Dispenzieri A, Dingli D, Hayman SR, Gertz MA, Rajkumar SV, Kapoor P. Venetoclax for the treatment of multiple myeloma: outcomes outside of clinical trials. Am J Hematol. 2021;96(9):1131–1136. doi: 10.1002/ajh.26269.

In this article we forgot to acknowledge that the work was supported by the Paul Calabresi K12 Career Development Award (CA90628-21).

We apologize for this error.

更新日期：2024-06-11

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南